electroCore to Participate in Upcoming Investor Conferences

Rhea-AI Summary

electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, has announced its participation in two upcoming investor conferences. CEO Dan Goldberger will attend the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference from August 12-13, 2024. Interested parties can contact Needham to schedule one-on-one meetings.

Additionally, CFO Brian Posner will be present at the 44th Annual Canaccord Genuity Growth Conference at the InterContinental Hotel in Boston, MA. electroCore will host investor meetings on August 13, 2024. To arrange a meeting, interested parties should contact Canaccord Genuity.

These conferences provide electroCore with opportunities to engage with investors and showcase their commercial-stage bioelectronic medicine and wellness solutions.

ROCKAWAY, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s CEO, Dan Goldberger, is scheduled to participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference August 12 - 13, 2024. Please contact Needham to schedule a 1x1 meeting.

In addition, Brian Posner, CFO of electroCore, Inc. is scheduled to attend the 44^th Annual Canaccord Genuity Growth Conference taking place at InterContinental Hotel in Boston, MA. electroCore will host 1x1 investor meetings on August 13, 2024. Please contact Canaccord Genuity to schedule a 1x1 meeting.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.

For more information, visit www.electrocore.com.

Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com

FAQ

Which investor conferences will electroCore (ECOR) participate in during August 2024?

electroCore (ECOR) will participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference from August 12-13, 2024, and the 44th Annual Canaccord Genuity Growth Conference on August 13, 2024.

Who will represent electroCore (ECOR) at the Needham Virtual MedTech & Diagnostics Conference?

Dan Goldberger, CEO of electroCore (ECOR), will represent the company at the Needham Virtual MedTech & Diagnostics Conference in August 2024.

Where will the Canaccord Genuity Growth Conference that electroCore (ECOR) is attending be held?

The 44th Annual Canaccord Genuity Growth Conference that electroCore (ECOR) is attending will be held at the InterContinental Hotel in Boston, MA.

How can investors schedule meetings with electroCore (ECOR) at these conferences?

Investors can contact Needham to schedule meetings at the Needham Virtual Conference, and Canaccord Genuity for meetings at their Growth Conference with electroCore (ECOR) representatives.